Risk factors for MEK-associated retinopathy in patients with advanced melanoma treated with combination BRAF and MEK inhibitor therapy

Booth, AEC; Hopkins, AM; Rowland, A; Kichenadasse, G; Smith, JR; Sorich, MJ

Booth, AEC (corresponding author), Flinders Univ S Australia, Coll Med & Publ Hlth, Bedford Pk, Adelaide, SA 5042, Australia.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020; 12 ():

Abstract

Background: Retinopathy is a common adverse event with mitogen-activated extracellular signal-regulated kinase (MEK) inhibitors. Little is known about......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索